|
|
|
Publications in Math-Net.Ru |
Citations |
|
2023 |
| 1. |
A. M. Andrianov, K. V. Furs, A. V. Gonchar, L. H. Aslanyan, A. V. Tuzikov, “Application of virtual screening and molecular modeling technologies to identify potential SARS-CoV-2 main protease inhibitors”, Mat. Biolog. Bioinform., 18:1 (2023), 15–32  |
1
|
|
2022 |
| 2. |
N. A. Shuldau, A. M. Yushkevich, K. V. Furs, A. V. Tuzikov, A. M. Andrianov, “Development of a deep learning generative neural network for computer-aided design of potential SARS-Cov-2 inhibitors”, Mat. Biolog. Bioinform., 17:2 (2022), 188–207  |
2
|
|
2021 |
| 3. |
A. M. Andrianov, A. M. Yushkevich, I. P. Bosko, A. D. Karpenko, Yu. V. Kornoushenko, K. V. Furs, A. V. Tuzikov, “Design and identification of potential HIV-1 entry inhibitors using In silico click chemistry and molecular modeling methods”, Mat. Biolog. Bioinform., 16:2 (2021), 317–334 |
|
2020 |
| 4. |
A. M. Andrianov, Yu. V. Kornoushenko, A. D. Karpenko, I. P. Bosko, Zh. V. Ignatovich, E. V. Koroleva, “Rational design of potential Bcr-Abl tyrosine kinase inhibitors by the methods of molecular modeling”, Mat. Biolog. Bioinform., 15:2 (2020), 396–415 |
1
|
|
2019 |
| 5. |
A. M. Andrianov, G. I. Nikolaev, Yu. V. Kornoushenko, Huang J., Jiang S., A. V. Tuzikov, “In silico identification of high-affinity ligands of the HIV-1 gp120 protein, potential peptidomimetics of neutralizing antibody N6”, Mat. Biolog. Bioinform., 14:2 (2019), 430–449 |
2
|
|
2018 |
| 6. |
A. M. Andrianov, G. I. Nikolaev, I. A. Kashin, A. V. Tuzikov, “Development of potential HIV-1 inhibitors by in silico click chemistry and molecular modeling methods”, Mat. Biolog. Bioinform., 13:2 (2018), 507–525 |
1
|
| 7. |
A. M. Andrianov, G. I. Nikolaev, I. A. Kashin, Y. V. Kornoushenko, S. A. Usanov, “Molecular modeling of novel non-steroidal aromatase inhibitors containing 1,2,4-triazole”, Mat. Biolog. Bioinform., 13:1 (2018), 290–307 |
1
|
|
2015 |
| 8. |
I. A. Kashyn, A. V. Tuzikov, A. M. Andrianov, “Identification of novel potential inhibitors of the HIV-1 gp41 protein by virtual screening and molecular modeling methods”, Mat. Biolog. Bioinform., 10:2 (2015), 325–343 |
3
|
|
2014 |
| 9. |
I. A. Kashyn, A. V. Tuzikov, A. M. Andrianov, “Virtual Screening of Novel Hiv-1 Entry Inhibitors Blocking Cd4-Binding Site of the Virus Envelope Gp120 Protein”, Mat. Biolog. Bioinform., 9:2 (2014), 359–372 |
3
|
|
2013 |
| 10. |
A. M. Andrianov, Yu. V. Kornoushenko, I. A. Kashyn, A. V. Tuzikov, “Computer-Aided Design of Novel HIV-1 Entry Inhibitors Based on Glycosphingolipids”, Mat. Biolog. Bioinform., 8:1 (2013), 258–275 |
1
|
| 11. |
A. M. Andrianov, I. A. Kashin, A. V. Tuzikov, “Computer-Aided Search for Novel Anti-Hiv-1 Agents Presenting Peptidomimetics of Neutralizing Antibodies and Evaluation of their Potential Inhibitory Activity by Molecular Modeling”, Mat. Biolog. Bioinform., 8:1 (2013), 119–134 |
2
|
|
2011 |
| 12. |
Yu. V. Kornoushenko, I. V. Anishchenko, A. V. Tuzikov, A. M. Andrianov, “Determination of the invariant structural elements for the third variable domain of the HIV-1 gp120 protein by molecular modeling”, Mat. Biolog. Bioinform., 6:2 (2011), 298–311 |
| 13. |
I. V. Anishchenko, A. V. Tuzikov, A. M. Andrianov, “Computer-aided design of the potential drugs for AIDS therapy: $\beta$-galactosylceramide and the HIV-1 gp120 V3 Loop”, Mat. Biolog. Bioinform., 6:2 (2011), 161–172 |
1
|
|
| Organisations |
|
| |
|
|
Contact us: